MoFo Represents MedEquities in Merger with Omega

Morrison & Foerster LLP is advising long-time client MedEquities Realty Trust, Inc. (NYSE: MRT) in its definitive merger agreement with Omega Healthcare Investors, Inc. (NYSEL OHI). As part of the transaction, Omega will acquire all outstanding MedEquities shares and MedEquities stockholders will receive a fixed exchange ratio of 0.235 Omega common shares plus $2 in cash for each share of MedEquities common stock held by them, which represents a value of $10.26 per MedEquities share based on the $35.15 closing price for Omega common stock on December 31, 2018. The enterprise value of the transaction is approximately $600 million.

MedEquities is a self-managed and self-administered real estate investment trust that invests in a mix of healthcare properties and healthcare-related real estate debt investments within the acute, post-acute and behavioral sectors of healthcare services.

MoFo previously advised MedEquities on the closing of its $239 million Initial Public Offering in 2016.

The MoFo deal team was led out of Washington D.C. by Corporate partner and co-chair of the firm’s REIT practice David Slotkin, Corporate partner Lauren Bellerjeau, and Corporate partner Andy Campbell.

Key support was provided by Corporate associates Marianne Marchiori (Washington D.C.) and Meredith Carr (Washington D.C.). Tax guidance was led by partner Shane Shelley (San Diego) and associate Jessica Stern (San Francisco). Compensation and Benefits support was led by partner Dom Bozzetti (New York) and of counsel Amanda Hines Gold (San Francisco).

For more information, please see the related press release.